key: cord-0716584-heg6hf4y
authors: Pan, Lu; Huang, Pan; Xie, Xia; Xu, Jiachen; Guo, Dawei; Jiang, Yuan
title: Reply to "Does MAFLD really increase the severity of COVID-19?"
date: 2020-11-04
journal: Dig Liver Dis
DOI: 10.1016/j.dld.2020.10.034
sha: 9314515020a8b5e6e26d1f16a5df87fe730d7177
doc_id: 716584
cord_uid: heg6hf4y

nan

We would like to thank Fajar et al. [1] for the appreciation and interest in our study, as well as the insightful comments and concerns. The Authors stress that our paper provided important information in the context of COVID-19 management, particularly in patients with MAFLD. At the same time, they raised some questions, the following points should be noted:

First, there were not relatively enough studies investigating the association between MAFLD and severity of COVID-19, therefore we included these letters in our meta-analysis.

The method used was supported by several published studies [1] [2] [3] [4] .

MAFLD and the total COVID-19, which provided sufficient data to calculate the pooled prevalence of MAFLD among patients with COVID-19. The method of pooled analysis has been used in many high-quality publications in the literature. [5] [6] [7] [8] Third, the definition of COVID-19 severity in our meta-analysis was described in the section on method, according to the criteria listed in the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Targher et al reported that MAFLD patients with neutrophil-tolymphocyte ratio (NLR) ≤ 2.8 were not associated with higher risk of severity of COVID-19 with adjusted odds ratio (5.32, 95%CI 0.98-29.90), in comparison to those without MAFLD and NLR ≤ 2.8. Since better data could not be obtained, thus we extracted the data in our pooled analysis for association between MAFLD and severity of COVID-19.

Does MAFLD really increase the severity of COVID-19?

The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics

The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulmonary medicine

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of infection

The Incidence of SARS-COV-2 Manifestations in the Central Nervous System: A Rapid Review and MetaAnalysis

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Unexpected Rapid Increase in the Burden of NAFLD in China From

Epidemiological Features of NAFLD From

None declared.